Australia at risk of falling behind USA and Europe in preventing deadly recurrence of Melanoma

23 August 2019

Federal government urged to provide certainty of access to immunotherapy for high risk melanoma patients.

Melanoma Institute Australia is urging the federal government to undertake a timely and efficient review of an immunotherapy treatment effective in preventing the deadly spread of melanoma, and fast track its listing on the Pharmaceutical Benefits Scheme (PBS).

Immunotherapy nivolumab was one of three treatments for resected Stage III metastatic melanoma submitted to the Pharmaceutical Benefits Advisory Committee (PBAC) for consideration for PBS listing.

All three treatments are effective in preventing melanoma recurrence and its spread to other organs including the brain, lungs and liver. Immunotherapy nivolumab is effective for the majority of these high risk patients.

This afternoon the federal government announced nivolumab had been deferred for further consideration, while a targeted combination therapy (effective for less than half these patients) was approved and a third treatment was rejected.

Co-Medical Directors of Melanoma Institute Australia, Professor Georgina Long and Professor Richard Scolyer, said whilst they were very pleased to see one treatment listed, they were disappointed for the majority of high risk melanoma patients that the immunotherapy treatment was not.

‘It is a sad irony that Australia has the highest melanoma rates in the world, yet we risk falling behind the USA and many European countries where this immunotherapy preventing melanoma recurrence in the majority of these high risk patients is already available and subsidised,’ said Professor Georgina Long.

‘Australian patients would like certainty that they will be able to access affordable immunotherapy treatment which has proven successful in clinical trials and which many hundreds of patients have been forced to access on compassionate grounds or face costs of tens of thousands of dollars,’ she said.

One Australian dies from melanoma every five hours. Melanoma Institute Australia is leading global efforts to find effective treatments for all melanoma patients, and eventually reach zero deaths from melanoma.

‘It is frustrating, disheartening and disappointing for Australia to be leading the international melanoma research effort, yet our own government is lagging behind the rest of the world in ensuring high risk patients have subsidised access to this proven immunotherapy treatment,’ Professor Scolyer added.

‘We urge the federal governent to fast track further consideration of this immunotherapy and remain hopeful it will eventually be listed on the PBS,’ he said.

04 Dec 2019

Community Fundraising November Wrap-Up

It’s time again to say thank you to our amazing community fundraisers!

03 Dec 2019

MIA & MPA Patient Information Evening videos now available

Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.

Tags: Melanoma treatment

22 Nov 2019

MIA shines in poster session

MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.

21 Nov 2019

MIA Co-Medical Director opens SMR Congress in USA

Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.

20 Nov 2019

Highly Cited Researchers List names MIA Co-Medical Directors

MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.

07 Nov 2019

MPA and MIA collaboration

Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.

04 Nov 2019

Community Fundraising October Wrap-Up

It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.

09 Oct 2019

Promising data for advanced melanoma patients

MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.

04 Oct 2019

Melanoma Information Forum

We are delighted to partner with Melanoma Patients Australia to host a Melanoma Information Forum at The Poche Centre on 6th November.

02 Oct 2019

Community Fundraising September Wrap-Up

Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.

26 Sep 2019

Notice for Supporters to Submit to PBAC

Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.

16 Sep 2019

Tune into Jay's Longest Melanoma March Channel 10 documentary

Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.

11 Sep 2019

Professor Georgina Long Co -Medical Director named Women of Influence in AFR Top 100 List

We are proud to announce that our Professor Georgina Long Co -Medical Director Melanoma Institute Australia has been named in the Top 100 Financial Review 2019 Women of Influence.

04 Sep 2019

Community Fundraising August Wrap-Up

It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.

02 Sep 2019

From Lab Coats To Lycra - Australian Melanoma experts take on world Triathlon championships

They are a formidable team - in work and in play – and one set to make history on both fronts.

30 Aug 2019

Melanoma Institute Australia hosts SunSafe Student Ambassador Programs 2019

This week, Melanoma Institute Australia hosted the first of six SunSafe Student Ambassador Programs for 2019.

Tags: SunSafe

23 Aug 2019